Phase II Study of Preoperative Radiation with Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients with Locally Advanced Rectal Cancer: ECOG 3204

BACKGROUND: Recent studies have demonstrated the feasibility of combining oxaliplatin with 5-FU or capecitibine and radiation therapy (RT). The addition of bevacizumab to chemotherapy improves overall survival for metastatic disease. We initiated a phase II trial to evaluate preoperative capecitabin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Landry, Jerome C., Feng, Yang, Cohen, Steven J., Staley, Charles A., Whittington, Richard, Sigurdson, Elin Ruth, Nimeiri, Halla, Verma, Udit, Prabhu, Roshan S., Benson, Al Bowen
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3620731/
https://ncbi.nlm.nih.gov/pubmed/23288663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27890
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge